A detailed history of Candriam S.C.A. transactions in Amgen Inc stock. As of the latest transaction made, Candriam S.C.A. holds 813,096 shares of AMGN stock, worth $215 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares
813,096
Previous 610,168 33.26%
Holding current value
$215 Million
Previous $191 Million 37.42%
% of portfolio
1.53%
Previous 1.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$309.38 - $337.38 $62.8 Million - $68.5 Million
202,928 Added 33.26%
813,096 $262 Million
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $20.5 Million - $25 Million
-78,192 Reduced 11.36%
610,168 $191 Million
Q1 2024

May 03, 2024

SELL
$268.87 - $324.56 $19.1 Million - $23.1 Million
-71,061 Reduced 9.36%
688,360 $196 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $26.2 Million - $29.5 Million
-102,316 Reduced 11.87%
759,421 $219 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $36.4 Million - $45.2 Million
166,615 Added 23.97%
861,737 $232 Million
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $66.6 Million - $78.7 Million
-310,684 Reduced 30.89%
695,122 $154 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $5.88 Million - $7.16 Million
26,020 Added 2.66%
1,005,806 $243 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $3.17 Million - $4.03 Million
13,861 Added 1.43%
979,786 $257 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $6.74 Million - $7.6 Million
30,010 Added 3.21%
965,925 $218 Million
Q2 2022

Aug 03, 2022

BUY
$230.71 - $256.74 $503,409 - $560,206
2,182 Added 0.23%
935,915 $228 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $49 Million - $54.2 Million
-223,380 Reduced 19.3%
933,733 $226 Million
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $9.41 Million - $10.8 Million
47,309 Added 4.26%
1,157,113 $260 Million
Q3 2021

Nov 09, 2021

BUY
$212.27 - $248.7 $31 Million - $36.3 Million
146,147 Added 15.17%
1,109,804 $236 Million
Q2 2021

Jul 20, 2021

SELL
$233.58 - $259.14 $84.2 Million - $93.4 Million
-360,548 Reduced 27.23%
963,657 $235 Million
Q1 2021

Apr 29, 2021

BUY
$221.91 - $258.6 $3,328 - $3,879
15 Added 0.0%
1,324,205 $292 Million
Q4 2020

Jan 22, 2021

BUY
$216.38 - $257.67 $13.4 Million - $15.9 Million
61,831 Added 4.9%
1,324,190 $304 Million
Q3 2020

Oct 19, 2020

BUY
$234.65 - $260.95 $91.8 Million - $102 Million
391,069 Added 44.88%
1,262,359 $321 Million
Q2 2020

Jul 23, 2020

SELL
$197.81 - $242.74 $6.66 Million - $8.17 Million
-33,678 Reduced 3.72%
871,290 $206 Million
Q1 2020

May 26, 2020

BUY
$182.24 - $241.7 $3,644 - $4,834
20 Added 0.0%
904,968 $213 Million
Q4 2019

Jan 21, 2020

SELL
$189.21 - $243.2 $649,368 - $834,662
-3,432 Reduced 0.38%
904,948 $218,000
Q3 2019

Feb 05, 2020

SELL
$174.11 - $208.62 $1,044 - $1,251
-6 Reduced -0.0%
908,380 $176 Million
Q3 2019

Oct 21, 2019

SELL
$174.11 - $208.62 $19.7 Million - $23.6 Million
-113,219 Reduced 11.08%
908,386 $177,000
Q2 2019

Aug 01, 2019

BUY
$166.7 - $195.41 $1.11 Million - $1.3 Million
6,646 Added 0.65%
1,021,605 $189 Million
Q1 2019

May 02, 2019

BUY
$180.87 - $203.88 $6.94 Million - $7.83 Million
38,384 Added 3.93%
1,014,959 $194 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $17.6 Million - $20.5 Million
-98,475 Reduced 9.16%
976,575 $190 Million
Q3 2018

Nov 07, 2018

BUY
$185.29 - $208.89 $70.5 Million - $79.5 Million
380,562 Added 54.8%
1,075,050 $223 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $8.48 Million - $9.52 Million
51,039 Added 7.93%
694,488 $128 Million
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $3.17 Million - $3.7 Million
18,702 Added 2.99%
643,449 $110 Million
Q4 2017

Feb 07, 2018

BUY
$168.79 - $188.59 $27.2 Million - $30.4 Million
161,172 Added 34.77%
624,747 $109 Million
Q3 2017

Nov 03, 2017

BUY
$167.29 - $191.0 $77.6 Million - $88.5 Million
463,575
463,575 $86.4 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.